MedTrace Logo

Fecal Immunochemical Test for Advanced Adenoma Detection in Colorectal Cancer Screening

NCT05200611 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2022-01-21

No results posted yet for this study

Summary

Early detecting and removing of colorectal advanced adenomas can reduce incidence of colorectal cancer. In order to reduce the incidence of colorectal cancer, improve the early diagnosis of colorectal cancer, the investigators conducted this study to explore diagnostic accuracy of fecal immunochemical test in colorectal cancer screening population.

Conditions

Interventions

DIAGNOSTIC_TEST

Fecal Immunochemical Test

Participants with positive fecal immunochemical test results were further examined by colonoscopy.

Sponsors & Collaborators

  • The People's Hospital of Zhaoyuan City

    collaborator UNKNOWN

  • Shanghe People's Hospital

    collaborator UNKNOWN

  • Shandong University

    lead OTHER

Eligibility

Min Age
50 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-04
Primary Completion
2022-06-01
Completion
2022-07-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05200611 on ClinicalTrials.gov